Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
1946 results
-
Helping researchers plan for Medical Research Future Fund grant opportunities
You can now read about Medical Research Future Fund (MRFF) grant opportunities that are forecast to open from February 2023. -
PBS co-payment reduction – What pharmacists need to know
A lower Pharmaceutical Benefits Scheme (PBS) general co-payment from 1 January 2023 will help ease cost-of-living pressures for Australians. Here’s what pharmacists need to know to support their customers. -
Ozzie vs Mozzie
The Australian Government has launched a new advertising campaign to encourage Australians to take simple steps to protect themselves against mosquito borne viruses, like Japanese Encephalitis Virus. -
Have your say: National Dementia Action Plan
The National Dementia Action Plan is open for consultation. Find out about the plan and how to provide feedback. -
Preventing age-related vision loss
Optometrist researcher Lauren Ayton is improving diagnosis and treatment pathways for patients with age-related vision loss. -
Keeping young children, families, and educators safe during a health crisis
Early childhood educators have the right skills to prevent infectious diseases and communicate health information fast to families with young children. But during the COVID-19 pandemic, staff struggled to find relevant health information. -
World Cup success to continue through She Hoops
She Hoops launched as a lasting legacy from the success of the FIBA Women’s Basketball World Cup 2022. -
Medibank Private and AHM data breach
Find out what your need to do if your Medicare number, or Medicare provider number has been exposed. -
ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years (Pfizer 6 months to 4 years). -
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine. -
ATAGI update on boosters following COVID-19 meeting on 11 November 2022
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November 2022. -
Fraud costs NSW pharmacist two years in jail
A NSW pharmacist has been sentenced to two years imprisonment yesterday after pleading guilty to defrauding taxpayers of almost $290,000. -
World Antimicrobial Awareness Week – 18 to 24 November 2022
World Antimicrobial Awareness Week runs from 18 to 24 November every year with this year’s theme Preventing Antimicrobial Resistance Together. It’s an international initiative to increase awareness of the growing problem of resistance to antibiotics and other antimicrobial medicines. -
New COVID-19 variant leads to increase in cases
A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, on the increase in COVID-19 cases due to a new Omicron variant. -
Television interview with Professor Paul Kelly on The Today Show - Monday 7th November 2022
Read the transcript of the television interview with Chief Medical Office, Professor Paul Kelly on Covid 19 and OMICRON. -
Television interview with Professor Paul Kelly and Stephanie Ferrier on ABC News Breakfast on Monday 7 November 2022
Read the transcript of the television interview with Chief Medical Officer Paul Kelly on ABC News Breakfast, on COVID-19 and Rapid Antigen Tests. -
Television interview with Professor Paul Kelly on Sunrise (Seven) on Monday 7 November 2022
Read the transcript of the television interview with Chief Medical Officer Paul Kelly on Sunrise, on COVID-19 and Rapid Antigen Tests. -
Australian Medical Research and Innovation Priorities 2022-2024 finalised
The Australian Medical Research and Innovation Priorities 2022-2024 came into effect on 6 November 2022. They are the fourth set of priorities for the Medical Research Future Fund (MRFF). -
The Virtus Oceania Asia Games are here!
Brisbane is set to welcome hundreds of elite athletes in a celebration of sport inclusion -
Changes to the Practice Incentives Program Indigenous Health Incentive
Updates to the Practice Incentives Program Indigenous Health Incentive (PIP IHI) aim to improve continuity of care and health outcomes for First Nations people with chronic disease. -
$27.8 million for research to improve the health and wellbeing of First Nations people
Researchers can apply for funding under the 2022 Indigenous Health Research grant opportunity. Funding is from the Medical Research Future Fund (MRFF). -
Presentations and recordings from the recent Australia/New Zealand Allied Health Summit are now available
Revisit the Australia/New Zealand Allied Health Summit held in August 2022. This year’s theme was demonstrating the value and utility of allied health care. -
Consultation on the Million Minds Mental Health Research Mission
Consultation on the Roadmap and Implementation Plan for the Million Minds Mental Health Research Mission is now open. -
Report on the Million Minds Mental Health Research Mission
Read about the review of the Medical Research Future Fund’s (MRFF) Million Minds Mental Health Research Mission. -
Join our next Medical Research Future Fund webinar
We invite you to join us for our next Medical Research Future Fund (MRFF) webinar at 1:30pm (AEDT) on 15 November 2022.